Filing Details

Accession Number:
0001209191-11-057742
Form Type:
4
Zero Holdings:
No
Publication Time:
2011-11-22 18:23:35
Reporting Period:
2011-11-21
Filing Date:
2011-11-22
Accepted Time:
2011-11-22 18:23:35
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1333248 Cadence Pharmaceuticals Inc CADX Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1265783 M Hazel Aker C/O Cadence Pharmaceuticals, Inc.
12481 High Bluff Drive, Suite 200
San Diego CA 92130
Svp, Gc & Secretary No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2011-11-21 10,000 $4.16 3,745 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 14, 2011.
  2. This transaction was executed in multiple trades at prices ranging from a low of $4.06 to a high of $4.35. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.